Linkages to Care for Current/Former Incarcerated Citizens Living with Hepatitis C – Year Three Update The Community Access National Network (CANN) will host its Community Roundtable on “Linkages to Care for Current/Former Incarcerated Citizens Living with Hepatitis C – Year Three Update” on Wednesday, April 17, 2019 at the PhRMA Read more…
Canada’s prisoner service is considering opening overdose prevention sites as it expands a needle-exchange program that is now offered at a fifth institution for offenders who inject smuggled drugs. “At the very least, let’s start opening up (the sites) so we can get away from the needle-in-the-cell thing,” he said, Read more…
Press release from the Louisiana Department of Health March 26, 2019 The Louisiana Department of Health and Department of Corrections announced today their selection of Asegua Therapeutics LLC (a subsidiary of Gilead Sciences, Inc.) as their hepatitis C subscription model pharmaceutical partner, to provide the State with unrestricted access to Read more…
The first prospective study of direct-acting antivirals (DAAs) for hepatitis C virus (HCV) infection in patients with any type of cancer has not only demonstrated that the treatment is safe and efficacious in this population, but that attaining sustained virologic response (SVR) can confer eligibility to participate in chemotherapeutic trials. Read more…
By: Kat HumphriesMarch 14, 2019 There is a common misconception that people who inject drugs (PWID) don’t care about their health. However, their widespread participation in syringe access (needle exchange) and other available health services suggests otherwise. Stigma, complex involvement in shared experiences around substance use disorder, and moral investment Read more…
The Hawaii Department of Health and the Empire Liver Foundation are co-sponsoring a free webinar on the Clinical Management of Hepatitis C Date: Wednesday, April 10, 2019 Time: 8am – 9am (HST) or 2pm-3pm (EST) Learning objectives: Describe the epidemiology of hepatitis C (HCV) in the United States and Hawaii Read more…
The first study to evaluate the cost-effectiveness of hepatitis C virus (HCV) screening among pregnant women in the US in the era of direct-acting antiviral (DAA) treatment demonstrates that it would be “highly” cost effective, even in states with low HCV prevalence. The investigators called for the currently disparate guidelines Read more…
A team of Penn surgeons has successfully transplanted hepatitis C-infected hearts into uninfected patients and then cured them of the virus, according to a new study published by the American Journal of Transplantation. The clinical trial — which tested the safety of hepatitis C-infected donor organs — included 10 transplant Read more…
Tuesday, March 5 2019 2:00 pm ET Register for Part 1 of the Learning Collaborative here! HepCAP co-chair Jack will be speaking on treatment policy changes and how the Philadelphia Department of Public Health is expanding resources for screening and treatment! Topics covered in Part 1: HCV Programming in Community Read more…
Tuesday, March 5, 2019 Franklin Theater 6:00–7:30 pm Join the Franklin Institute for an important and insightful conversation around the national opioid crisis, and learn some of the innovative ways researchers are hoping to battle it. The Franklin Institute’s Chief Bioscientist Dr. Jayatri Das welcomes Dr. Yasmin Hurd, a prominent neurobiologist Read more…